Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Spirovant.ClinicalTrials
CONTACT
Lead
Spirovant Sciences, Inc.
This multi-center study is a first-in-human, single ascending dose, Phase 1/2 trial to evaluate the safety, pharmacokinetics, and pharmacodynamics of various dose levels in people with CF who are ineligible or intolerant to CFTR modulator therapy.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted